HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume  

 

 

If you want to download the article, please login or register as reader.

2024

Heroin Addiction and Related Clinical Problems: 2024, 26, 1

Effect of changes in life-related factors on mood status and life quality of methadone maintenance therapy (MMT) patients after withdrawal from MMT

Penghui Cao, Qiaofang Huang, Nannan Pan, Huaxin Li, Daoyi Feng, and Ziyan Fang

Heroin Addiction and Related Clinical Problems: 2024, 26, 2

Somatic and mental health among older patients in opioid agonist therapy: a cross-sectional geriatric assessment study

Lennart Niels Mayer-Eckardt, Ole Gnirss, Maximilian Meyer, Katharina Roser, Kenneth M. Dürsteler, and Marc Vogel

Heroin Addiction and Related Clinical Problems: 2024, 26, 3

Micro-dosing with buprenorphine when switching from full agonists (methadone, SR-morphine) to buprenorphine treatment in opioid agonist-assisted treatment programmes in Slovenia

Miha Lavre, and Andrej Kastelic

Heroin Addiction and Related Clinical Problems: 2024, 26, 4

Is the SCL90-based five-dimensional structure able to differentiate Heroin Use Disorder patients with low and high benzodiazepine dependence symptomatology?

Angelo G. I. Maremmani, Filippo Della Rocca, Silvia Bacciardi, Mario Miccoli, and Icro Maremmani

Heroin Addiction and Related Clinical Problems: 2024, 26, 5

International perspectives on opioid use disorder and treatment: Results from an online convenience sample

Katrine Melby, Mehdi Farokhnia, Serenella Tolomeo, Roshan Bhad, Jørgen G. Bramnes, Alex Baldacchino, Ravindra Rao, Gomathinayagam Kandasami, Jenna L. Butner, Vicky Phan, Francina Fonseca, Parnian Rafei, Long Jiang, Georgios Tzeferakos, and Geert Dom

Heroin Addiction and Related Clinical Problems: 2024, 26, 6

The effective management of Addiction: An Italian Experts’ Opinion using a Nominal Group Technique (NGT) Approach

Simone De Persis, Alessandro Pallucchini, Monica Baiano, Arianna Camporese, Rossella Garofano, Francesco Mancuso, Ilenia Zanoni, Marialuisa Grech, and Salvatore de Fazio

Heroin Addiction and Related Clinical Problems: 2024, 26, 7

Psychometric evaluation of two patients monitored for 12 weeks after switching from racemic methadone to levomethadone agonist therapy

Gabriele Pasquale De Luca, Gaia Anibaldi, Danilo Paolucci, Paola Motta, and Simone De Persis

Heroin Addiction and Related Clinical Problems: 2024, 26, 8

Efficacy and safety of naldemedine in the long-term treatment of opioid-induced constipation in patients on methadone agonist therapy monitored for three consecutive months

Emanuele Corbucci, and Piero Pierucci

Heroin Addiction and Related Clinical Problems: 2024, 26, 9

Beginning with buprenorphine depot: characteristics and experiences of the first patients in a French addictions centre.

Alice Deschenau, Amir Al Tabchi, Marie-Charlotte Noury, Léa Micheletti, Husen Ali-Diabacte, Elisa Vodislav, Nathalie Texier, Sarah Hervy, and Didier Touzeau

Heroin Addiction and Related Clinical Problems: 2024, 26, 10

The effects of heroin on pregnant rats and the reproductive system of female offspring

Fatemeh Osanloo, Ramin Hajikhani, Gholamhassan Vaezi, and Maryam Bananej

Heroin Addiction and Related Clinical Problems: 2024, 26, 11

Pet ownership, physical activity and mental health among people in opioid maintenance treatment: a prospective, observational study

Cornelia Haarr Hatlo, Thomas Clausen, Ashley Elizabeth Muller, and Gustavo Sugahara

Heroin Addiction and Related Clinical Problems: 2024, 26, 12

Suicidal behaviour and its risk factors in patients with opioid use disorder

İpek Buse Güzelce, Bulent Kadri Gultekin, and Muhsin Koray Kılıç

Heroin Addiction and Related Clinical Problems: 2024, 26, 13

Satisfaction of patients on methadone maintenance treatment with changing policies during the COVID-19 pandemic

Anat Sason, Marsha Weinstein, Miriam Adelson, Shaul Schreiber, and Einat Peles

Heroin Addiction and Related Clinical Problems: 2024, 26, 14

The relationships among withdrawal symptoms and depression in IV injection and non-injection groups in a population of heroin users

Kunhua Lee, and Cheng Fang Yen

Heroin Addiction and Related Clinical Problems: 2024, 26, 15

The Impact of Chronic Pain and Depression on Medication for Opioid Use Disorder Treatment: A Mixed-Methods Analysis

Corinne N. Kacmarek, Hannah C. Smith, Maxwell Kuehn, Melanie E. Bennett, Annabelle Belcher, Heather Fitzsimons, William Hall, Aaron Greenblatt, Lan Li, and Letitia Travaglini

Heroin Addiction and Related Clinical Problems: 2024, 26, 16

Using genetic parameters to predict somatization in females with heroin dependence

Kadir Uludag, Hang Su, Haifeng Jiang, Jiang Du, Na Zhong, and Min Zhao

Heroin Addiction and Related Clinical Problems: 2024, 26, 17

Invisible: An exploratory study of the impact of COVID-19 restrictions on people who use heroin

Daniela-Irina Stadniciuc, Marie-Claire Van Hout, Stephanie Kewley, and Georgina Mathlin

Heroin Addiction and Related Clinical Problems: 2024, 26, 18

The severity of Heroin Use Disorder in patients at treatment entry and their therapeutic response to Opioid Agonist Treatment

Filippo Della Rocca, Francesco Lamanna, Lucia Massa, Giulia De Luca, Mario Miccoli, Icro Maremmani, and Angelo G. I. Maremmani

Heroin Addiction and Related Clinical Problems: 2024, 26, 19

"Life feels better with the right medication". Results from a service user organization-led survey of opioid maintenance treatment patients in Norway

Gabrielle K. Welle-Strand, Marianne Pierron, Ida Kristine Olsen, Ronny Bjørnestad, and Rebecca McDonald

Heroin Addiction and Related Clinical Problems: 2024, 26, 20

Maternal Buprenorphine split dosing

Cindy Flores, Usman Riaz, Peter Tenore, and Nazar Muhammad

Heroin Addiction and Related Clinical Problems: 2024, 26, 21

Heroin addiction history, psychopathology and stress sensitivity in a sample of migrants to Italy

Manuel Glauco Carbone, Claudia Tagliarini, Filippo Della Rocca, Marina Ricci, Anna M. Lupi, Lucia Sarandrea, Angela Ceban, Pietro Casella, Icro Maremmani, and Angelo G. I. Maremmani

Heroin Addiction and Related Clinical Problems: 2024, 26, 22

HCV-RNA viral load fingerstick assay to simplify screening and linkage to care of people who use drugs attending Italian addiction treatment centres: A pilot project

Sarah Vecchio, Claudio Leonardi, Luigi Bartoletti, Daniela Mussi, Roberta Gaudenzi, Eugenia Vernole, Duncan Hill, Matteo Pacini, and Lorenzo Somaini

Heroin Addiction and Related Clinical Problems: 2024, 26, 23

Night eating syndrome, impulsivity, sleep disorder and craving in opioid use disorder patients in remission phase

Pınar Erdogan Turkmen, Ali Erdogan, and Burak Kulaksızoglu

Heroin Addiction and Related Clinical Problems: 2024, 26, 24

Addressing methamphetamine use in opioid use disorder treatment: Clinical perspectives

Mustafa Danışman, Gamze Zengin İspir, and Kübra Sezer Katar

Heroin Addiction and Related Clinical Problems: 2024, 26, 25

Group counselling can prolong the remission period in opioid use disorder patients after detoxification and enhance social support, self-efficacy and hopelessness levels in patients and their families in Turkey.

Belgin Varol, and Fatma Oz

Heroin Addiction and Related Clinical Problems: 2024, 26, 26

A community-based tele medication-assisted treatment (TMAT) for delivery of methadone maintenance treatment (MMT) during the COVID-19 pandemic in India: A single-arm, prospective feasibility study

Roshan Bhad, Deepak MB, Vinit Patel, Jaswant Jangra, Ravindra Rao, and Pooja Shakya

Heroin Addiction and Related Clinical Problems: 2024, 26, 27

Pattern of illicit drug use in Sri Lanka; A detailed analysis from a country of transient point for drug trafficking

Nuwan Darshana, Champa Wijesinghe, and Vijitha De Silva

Heroin Addiction and Related Clinical Problems: 2024, 26, 28

Liver function and lead levels increase by oral and inhaled opium use in Iranian addiction treatment centres

Mohamad Ghaiedi, Zahra Barmoudeh, zahra daneshyar, Janmohamad Malekzadeh, and Sajad Hassanzadeh

Heroin Addiction and Related Clinical Problems: 2024, 26, 29

Socio-demographic characteristics and patterns of substance use disorder in Montenegro

Ena Grbovic, and Bojana Miletic

Heroin Addiction and Related Clinical Problems: 2024, 26, 30

Recruiting and Retaining Patients in Low Threshold Opioid Agonist Treatment: A Retrospective Cohort Study

Kathleen Henriksen, Jon-Aksel Jacobsen, Elliott Henriksen, Leni Gomes, Linda Elise Wüsthoff, Espen Ajo Arnevik, and Peter Krajci

Heroin Addiction and Related Clinical Problems: 2024, 26, 31

The effect of intravenous heroin injection on gene expression in HIV-1 infected people

Ahmad Hosseinzadeh Adli, and Seyed Mohammad Jazayeri

Heroin Addiction and Related Clinical Problems: 2024, 26, 32

Prevalence of psychiatric and physical comorbidities in patients diagnosed with opioid use disorder (OUD) in Lanarkshire, Scotland. 2018-2019: cross-sectional study

Hanan Khaled Ali Al-Shemali, Duncan Hill, Tatiana Chama Borges Luz, and Louise Evans

Heroin Addiction and Related Clinical Problems: 2024, 26, 33

Raha syrup attenuates the severity of physical and psychological dependence and voluntary morphine consumption in morphine-withdrawn rats receiving the opium tincture maintenance treatment

Hajar Yazdani, Mahdi Zahedi-Khorasani, Ali Ghanbari, Ali Khaleghian, and Hossein Miladi-Gorji

Heroin Addiction and Related Clinical Problems: 2024, 26, 34

The maintenance treatment with opium tincture and exercise normalize the electroencephalographic changes and reduce visual image-induced craving in opioid use disorder patients

Mahya Bavisi, Roshanak Tirdad, Raheb Ghorbani, Masoud Hajirasouli, Reza Khosrowabadi, and Hossein Miladi-Gorji

Heroin Addiction and Related Clinical Problems: 2024, 26, 35

Effects of heroin and other illicit drug usage on family and social network in Sri Lanka. Evidence from a cross sectional study

Nuwan Darshana, Champa Wijesinghe, and Vijitha De Silva

Heroin Addiction and Related Clinical Problems: 2024, 26, 36

Illicit drug use among Sri Lankan school-going adolescents: A Qualitative study

Amila Chandrasiri, Nuwan Darshana, Ishara Wanniaracchchi, Sajeewa De Silva, and Konara Somarathne

Heroin Addiction and Related Clinical Problems: 2024, 26, 37

Mental well-being and illicit drug use related risk factors in Sri Lankan institutionalised male drug users

Nuwan Darshana, Champa Wijesinghe, and Vijitha De Silva

Heroin Addiction and Related Clinical Problems: 2024, 26, 38

Determination of sexual functioning, quality of life levels, and healing factors of substance-abusing men who continue the rehabilitation program in Turkey

Melike Dişsiz

Heroin Addiction and Related Clinical Problems: 2024, 26, 39

Association between religiosity/spirituality and opioid abuse: A systematic review

Alessandra Buja, Laura Montecchio, Daniele Vo, and Roberta Lo Bue

Heroin Addiction and Related Clinical Problems: 2024, 26, 40

Amphetamine and amphetamine-like compounds, new psychoactive substances (NPS), and synthetic cathinones. State of the problem in Russia and Belarus

Tatyana V. Klimenko, Svetlana M. Shakhova, Alexander A. Kozlov, and Sergey A. Igumnov

Heroin Addiction and Related Clinical Problems: 2024, 26, 41

The effect of the physician-nurse-social worker linkage rehabilitation model on the psychological status of MMT patients

Qiaofang Huang, Shanfang Su, Lian Duan, Junyi Lin, Caimei Zou, Shaojuan Wu, and Shichao Xu

Heroin Addiction and Related Clinical Problems: 2024, 26, 42

Extended-release subcutaneous buprenorphine. The 3rd therapeutic revolution

Marc Reisinger

Heroin Addiction and Related Clinical Problems: 2024, 26, 43

Clinical characterisation of dual depression and association with bipolarity features

Margherita Barbuti, Jean-Michel Azorin, Jules Angst, Charles L. Bowden, Sergey Mosolov, Allan H. Young, Eduard Vieta, Giulio Perugi, and Icro Maremmani

Heroin Addiction and Related Clinical Problems: 2024, 26, 44

Exploring Theory of Mind and Empathy Progression Alongside Cognitive Gains in Methadone Maintenance Treatment

Shlomit Zorani, and Einat Peles

Heroin Addiction and Related Clinical Problems: 2024, 26, 45

Evaluation of the introduction of buprenorphine – naloxone oro-adhesive film formulation to patients in NHS Lanarkshire

Duncan R. B. Hill

Heroin Addiction and Related Clinical Problems: 2024, 26, 46

Perinatal Injectable Opioid Agonist Therapy (iOAT) Treatment Experience: A Qualitative Study

Charissa Patricelli, Ruth Liu, Shanlea Gordon, Nicole Carter, Karly Stewart, Isabelle Gouin, Vanessa Paquette, Jeff Bone, and Karen Urbanoski

Heroin Addiction and Related Clinical Problems: 2024, 26, 47

Sociodemographic and Clinical Factors of Dropout from Inpatient Detoxification Treatment in Patients with Opioid Use Disorders

Rahime Dicle Cetiner Akgul, Mine Ergelen, Selim Arpacıoglu, and Murat Yalcın

Heroin Addiction and Related Clinical Problems: 2024, 26, 48

Hospital admissions for alcohol, opioids, cannabinoids and sedatives or hypnotics related intoxications among children, adolescents and young adults in Slovenia: the period before and after the start of the COVID-19 pandemic

Mercedes Lovrecic, Mateja Rok Simon, Ales Korosec, and Barbara Lovrecic

Heroin Addiction and Related Clinical Problems: 2024, 26, 49

The estimated and actual prevalence of dementia among heroin addicts in opioid agonist treatment and comparison with general population, In Slovenia

Mercedes Lovrecic, Icro Maremmani, Manuel Glauco Carbone, and Barbara Lovrecic

Heroin Addiction and Related Clinical Problems: 2024, 26, 50

Clinical characteristics of Substance Use Disorders elderly patients: a look at a Swiss psychogeriatric inpatient unit

Vincenza Spera, Alireza Moor, Manuel Glauco Carbone, and Icro Maremmani

Heroin Addiction and Related Clinical Problems: 2024, 26, 51

Buprenorphine with and without Gabapentin and Clonidine in detoxification of 5-16 year-old children with Opioid Use Disorder: a randomised controlled trial

Mahin Eslami Shahrbabaki, Habibeh Ahmadipour, Atefeh Ahmadi, Mohammadamin Abdi, Zahrasadat Shiva, and Marjan Shamspour

Heroin Addiction and Related Clinical Problems: 2024, 26, 52

The rise of the 'Opiate Rule' - A dismal parenthesis for Opioid Agonist Treatment in Sweden from 2010 to 2016

Bodil Monwell

Heroin Addiction and Related Clinical Problems: 2024, 26, 53

The Opiate Rule - An inferior regulating of opioid agonist treatment in Sweden 2010-2016 and how was it handled in practice

Bodil Monwell

Heroin Addiction and Related Clinical Problems: 2024, 26, 54

Remission Rates of Patients with Opioid Use Disorder Who Got Naltrexone Implantation: A Retrospective Study

Mustafa Danışman, Seyit Murat Aydın, Gamze Zengin İspir, Kübra Sezer Katar, and Mustafa Batuhan Kurtoğlu

Heroin Addiction and Related Clinical Problems: 2024, 26, 55

Intervention on Dual Disorders: the role of qualitative evaluation for psychopathology observation and psychotherapy research on causation

Emanuela Atzori

Heroin Addiction and Related Clinical Problems: 2024, 26, 56

Consumption Patterns and Relevant Habits of Patients on Methadone Maintenance Therapy in Tehran, Iran

Reyhaneh Mehrvar, Saeideh Soltani, and Ali Kheradmand

Heroin Addiction and Related Clinical Problems: 2024, 26, 57

Medical Adjustment of Alcohol Use Disorder (AUD) with Opioids

Albrecht Ulmer

Heroin Addiction and Related Clinical Problems: 2024, 26, 58

Need for opioid agonist therapy among opioid users of open drug scenes

Heike Zurhold, Silke Kuhn, Jens Reimer, and Uwe Verthein

Heroin Addiction and Related Clinical Problems: 2024, 26, 59

Gambling prevalence in patients with dependence on different psychoactive substances

Zuzana Kamendy, Adam Kurilla, and Lubomir Okruhlica

Heroin Addiction and Related Clinical Problems: 2024, 26, 60

Opioid agonist maintenance treatment in kyrgyzstan: Assessing patients’ changing medical and psychosocial needs over the course of treatment

Zhyldyz Bakirova, Ulla Pape, and Ingo Ilja Michels

Heroin Addiction and Related Clinical Problems: 2024, 26, 61

Evaluating Substance-Related Dreams and Their Impact on The Treatment Process Through the Mechanism of Censorship in Dreams. A Pilot Study

Mustafa Danisman, Claudio Colace, Safak Yalcin Sahiner, and Hakki Polat

Heroin Addiction and Related Clinical Problems: 2024, 26, 62

Investigating the Association Between Heroin Dose, Genetics, and Personality Disorders

Kadir Uludag, Hang Su, Haifeng Jiang, Jiang Du, Na Zhong, and Min Zhao

 

EUROPAD - European Opiate Addiction Treatment Association Rolex replica
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page